Biostar Microtech International Corp.
TWSE:2399.TW
33.2 (TWD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,344.435 | 2,236.385 | 2,774.796 | 2,104.572 | 2,279.734 | 3,040.055 | 3,443.392 | 2,997.576 | 2,830.595 | 4,150.648 | 4,608.578 | 5,357.683 | 6,948.151 | 6,924.588 | 7,702.915 |
| Cost of Revenue
| 2,213.393 | 1,967.765 | 2,254.663 | 1,851.165 | 2,024.132 | 2,750.636 | 2,988.208 | 2,650.542 | 2,646.519 | 3,790.313 | 4,173.559 | 4,687.758 | 6,084.025 | 6,005.342 | 6,623.807 |
| Gross Profit
| 131.042 | 268.62 | 520.133 | 253.407 | 255.602 | 289.419 | 455.184 | 347.034 | 184.076 | 360.335 | 435.019 | 669.925 | 864.126 | 919.246 | 1,079.108 |
| Gross Profit Ratio
| 0.056 | 0.12 | 0.187 | 0.12 | 0.112 | 0.095 | 0.132 | 0.116 | 0.065 | 0.087 | 0.094 | 0.125 | 0.124 | 0.133 | 0.14 |
| Reseach & Development Expenses
| 73.555 | 71.88 | 98.07 | 71.283 | 71.188 | 90.255 | 104.543 | 101.508 | 114.317 | 107.03 | 117.769 | 130.669 | 120.819 | 131.98 | 108.625 |
| General & Administrative Expenses
| 71.533 | 55.8 | 80.794 | 76.537 | 131.874 | 115.043 | 74.585 | 46.029 | 81.821 | 89.443 | 83.711 | 99.586 | 84.09 | 114.598 | 124.639 |
| Selling & Marketing Expenses
| 120.272 | 138.21 | 149.246 | 132.205 | 122.664 | 148.497 | 183.631 | 256.242 | 158.746 | 188.166 | 178.948 | 300.652 | 420.595 | 247.816 | 294.298 |
| SG&A
| 187.293 | 194.01 | 230.04 | 208.742 | 254.538 | 263.54 | 258.216 | 302.271 | 240.567 | 277.609 | 262.659 | 400.238 | 504.685 | 362.414 | 418.937 |
| Other Expenses
| 0 | 0.324 | 181.402 | 196.346 | 146.464 | -134.145 | -1.617 | 32.571 | 54.846 | -14.938 | 103.359 | 19.947 | 69.254 | 23.74 | 31.143 |
| Operating Expenses
| 260.848 | 265.89 | 328.11 | 280.025 | 325.726 | 353.795 | 362.759 | 403.779 | 354.884 | 384.639 | 380.428 | 530.907 | 625.504 | 494.394 | 527.562 |
| Operating Income
| -129.806 | 17.53 | 382.2 | 182.294 | 76.34 | -64.376 | 92.425 | -56.745 | -170.808 | -24.304 | 54.591 | 139.018 | 238.622 | 424.852 | 551.546 |
| Operating Income Ratio
| -0.055 | 0.008 | 0.138 | 0.087 | 0.033 | -0.021 | 0.027 | -0.019 | -0.06 | -0.006 | 0.012 | 0.026 | 0.034 | 0.061 | 0.072 |
| Total Other Income Expenses Net
| 12.783 | -1.323 | 24.641 | -0.7 | -102.102 | -134.802 | -1.792 | 32.56 | 54.894 | -14.953 | 103.329 | 3.14 | 142.265 | -79.905 | -12.659 |
| Income Before Tax
| -117.023 | 16.207 | 406.841 | 181.594 | 66.264 | -199.178 | 90.633 | -24.185 | -115.989 | -39.257 | 157.92 | 124.338 | 380.887 | 344.947 | 538.887 |
| Income Before Tax Ratio
| -0.05 | 0.007 | 0.147 | 0.086 | 0.029 | -0.066 | 0.026 | -0.008 | -0.041 | -0.009 | 0.034 | 0.023 | 0.055 | 0.05 | 0.07 |
| Income Tax Expense
| -3.663 | 3.356 | 45.166 | 40.266 | 20.391 | -8.682 | -14.301 | 8.63 | -11.666 | 26.859 | 35.3 | 26.255 | 75.37 | 74.509 | 131.809 |
| Net Income
| -113.36 | 12.851 | 361.675 | 142.691 | 45.873 | -243.252 | 100.415 | -32.815 | -104.323 | -66.116 | 122.62 | 98.083 | 305.517 | 270.438 | 407.078 |
| Net Income Ratio
| -0.048 | 0.006 | 0.13 | 0.068 | 0.02 | -0.08 | 0.029 | -0.011 | -0.037 | -0.016 | 0.027 | 0.018 | 0.044 | 0.039 | 0.053 |
| EPS
| -0.64 | 0.072 | 2.03 | 0.8 | 0.26 | -1.37 | 0.56 | -0.18 | -0.59 | -0.37 | 0.69 | 0.66 | 1.72 | 1.52 | 1.08 |
| EPS Diluted
| -0.64 | 0.072 | 2.01 | 0.8 | 0.26 | -1.37 | 0.56 | -0.18 | -0.59 | -0.37 | 0.68 | 0.65 | 1.68 | 1.49 | 1.08 |
| EBITDA
| -112.552 | 24.165 | 390.183 | 193.055 | -11.274 | -109.875 | 113.276 | -9.735 | -99.889 | -26.112 | 175.054 | 145.468 | 405.404 | 456.055 | 595.899 |
| EBITDA Ratio
| -0.048 | 0.011 | 0.141 | 0.095 | 0.051 | -0.036 | 0.032 | -0.003 | -0.035 | -0.006 | 0.038 | 0.03 | 0.038 | 0.066 | 0.077 |